KCRS19
(Kidney Cancer Research Summit – 1st Annual)
Sept 12-13, 2019
Philadelphia, PA
This is what started as a grassroot meeting for all the RCC community focusing on science, ultimate collaboration and inclusiveness. All in the hope of helping our patients live better, live longer and dream of the cure. Why not?? Isn’t it what we all want if we get this disease ???
I feel this is the beginning of something very very special.
Toni Choueiri, MD Dana-Farber Cancer Institute
Toni Choueiri, MD, Dana-Farber Cancer InstituteDear Susan, Bryan, Hans, Toni, steering committee members and all of you who participated in the planning, speaking, or moderating this inaugural meeting:
Kudos to all of you for an engaging and informative meeting!
To Ralph and Brenda: Thank you for inspiring us and reminding us of the urgency of our research. This is what all of our work is about, making a difference in the lives of patients with RCC, that they may have life and have it abundantly.
Nizar Tannir, MD
MD Anderson Cancer Center
Nizar Tannir, MD, MD Anderson Cancer CenterKidney Cancer Coalition & KCAN: Stronger Together
Kidney Cancer Coalition and KCAN have joined forces to accelerate life-saving research and clinical trials for kidney cancer.
The union of these two complementary charitable organizations represents a promising step for the kidney cancer community.
Together, we’ll be known as KidneyCan—carrying that name forward while embracing the “CAN” legacy to reinforce our driven and optimistic vision for our role in the fight against this deadly disease.
Battling what is among the most prevalent forms of cancer among men (#6) and women (#10) in the U.S.*—yet still among the most under-funded and under-recognized cancers— patients, caregivers, advocates, and scientists are in dire need of greater awareness, funding, and action. That is our focus.
As one, we bring proven effectiveness at raising money for research—from grassroots efforts, to private contributions and corporate grants, up through substantial federal funding. Our impact in just four combined years of existence includes:
• Spearheading efforts to initiate a $45 million Congressional grant program for research;
• Raising over $1 million through local efforts and events including our “Rock the Cure” fundraisers, with over $725,000 already put to work in research labs and studies;
• Leading the first-ever grassroots-funded clinical trial for kidney cancer; and
• Earning a reputation for being extremely efficient at deploying capital directly to clinical and scientific endeavors in pursuit of breakthroughs.
Our founders—Brenda and Ralph Knapp, who started KC Coalition in 2016, and Bryan Lewis, who formed KCAN in 2017—recognized the potential benefits of pooling their strengths and resources. These three devoted leaders have personal experiences with kidney cancer, as patients, caregivers, and advocates. Their commitment to the cause is profound.
KIDNEY CANCER ADVOCACY DAY 2019
Join us Oct. 21-22 for our Community advocacy day on the Hill
Please join us to let your voice be heard
In the News
World Kidney Cancer Day!
House passes Defense bill which includes $30M for Kidney Cancer Research
World Kidney Cancer Day June 20, 2019
Keytruda-Inlyta Combo Approved by FDA for Untreated Advanced Kidney Cancer immuno-oncologynews.com
Budget Caps & Cancer Research. Is there a connection?
Since our inception in 2016, we have proudly given over $725,000 to Kidney Cancer Research!
WE ARE A GRASSROOTS ORGANIZATION DEDICATED TO MAKING A DIFFERENCE IN THE KIDNEY CANCER COMMUNITY
Funded major projects to date include:
-
RADVAX investigator led immunotherapy trial for 25 advanced kidney cancer patients at UT Southwestern combining Nivolumab, Ipilimumab and SBRT.
-
Support of UT Southwestern’s Kidney Cancer Research Program. 1 of only 2 SPOREs (Specialized Programs of Research Excellence) for Kidney Cancer in the US.
Our primary sources of support are donations from the general public and fundraising.
Our mission is to abolish Kidney Cancer as a threat to the life and health of patients through advocacy and accelerating research by offering direct financial support for clinical and laboratory researchers with promising ideas.
Kidney Cancer strikes 63,340/year
14,970/year die from the disease
We want to help change those statistics!
Please enter your information below: